Iodide

Iodide

SCHEMBL22345479

CCOP(=O)(CC)c1c[n+](C)nc2ccccc12.[I-]

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.34
▸ MEN1 O00255 4/20 0.34
▸ UTRN P46939 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ HPGD P15428 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ AOX1 Q06278 1/20 0.33
▸ NR1I2 O75469 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.32
▸ NPY5R Q15761 1/20 0.32
▸ KCNH2 Q12809 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ ELANE P08246 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL22345589 0.78 NPY5R (0.42) KMT2AMEN1KDM4EHPGDLMNA
SCHEMBL22345540 0.78 — —
SCHEMBL22345526 0.77 NPY5R (0.43) KMT2AMEN1KDM4EHPGDLMNA
SCHEMBL22345536 0.76 NR1I2 (0.37) KMT2AMEN1KDM4EHPGDLMNA
Iodide SCHEMBL22345422 0.75 NPY5R (0.35) KMT2AMEN1KDM4EHPGDLMNA
SCHEMBL22345518 0.74 MEN1 (0.36) KMT2AMEN1UTRNKDM4EHPGD
SCHEMBL22345432 0.72 POLB (0.31) POLB
SCHEMBL22345481 0.72 TBXAS1 (0.37) KMT2AMEN1KDM4EHPGDLMNA
SCHEMBL22345428 0.72 DDAH1 (0.30) L3MBTL1
SCHEMBL22557730 0.71 MAPT (0.32) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2022-05-05 — — US disclosed
EP-3924344-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH Syngenta Crop Protection AG (CH) 2021-12-22 — — EP disclosed
CN-113423694-A Cinnolinium compounds for use in a method for controlling unwanted plant growth 先正达农作物保护股份公司 2021-09-21 — — CN disclosed
WO-2020164970-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH SYNGENTA CROP PROTECTION AG (CH) 2020-08-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220132847-A1 CINNOLINIUM COMPOUNDS FOR USE IN A METHOD OF CONTROLLING UNWANTED PLANT GROWTH NOTUM, DDT, CYP51A1 KMT2A 3742/4885MEN1 603/4885UTRN 2449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback